Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease

Blood. 1996 Aug 1;88(3):1113-21.

Abstract

The development of graft-versus-host disease (GVHD) is associated with long-lasting and profound deficits in immune function that lead to increased morbidity and mortality after bone marrow transplantation (BMT). We investigated a mechanism of T-cell immunodeficiency in response to mitogen or alloantigen in an experimental model of acute GVHD by analyzing the roles of two immunosuppressive moieties: interferon gamma (IFN-gamma) and nitric oxide (NO). Splenocytes from mice with GVHD did not proliferate either to the T-cell mitogen, concanavalin A (Con A), or to host alloantigens, but only mitogen-activated cultures produced increased levels of NO. The abrogation of NO synthesis with LG-mono-methyl-arginine (NMMA) restored mitogen-induced proliferation but not the response to host antigens. The mechanism of impared proliferation to mitogen was dependent on IFN-gamma because blockade of this cytokine in culture inhibited NO production and restored proliferation to Con A to levels similar to those in transplanted control mice without GVHD. NMMA did not substantially reduce IFN-gamma levels, demonstrating that NO acted distally to IFN-gamma in the pathway of immunosuppression in response to mitogen. Furthermore, the prevention of IFN-gamma production in vivo after allogeneic BMT, by transplantation of polarized type 2 donor T cells (secreting interleukin-4 but not IFN-gamma), also prevented NO production and restored splenocyte responses to mitogen. Our data demonstrate the existence of NO-dependent and NO-independent pathways involved in suppression of T-cell proliferation during acute GVHD. Excess NO synthesis appears to be one mechanism by which IFN-gamma induces immunodeficiency after allogeneic BMT.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Bone Marrow Transplantation
  • Concanavalin A / pharmacology*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Female
  • Graft vs Host Disease / immunology*
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / pharmacology*
  • Interleukin-4 / biosynthesis
  • Interleukin-4 / metabolism
  • Isoantigens / immunology
  • Lymphocyte Activation / drug effects*
  • Mice
  • Mice, Inbred C57BL
  • Mitogens / pharmacology*
  • Nitric Oxide / biosynthesis
  • Nitric Oxide / physiology*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Radiation Chimera
  • Spleen / pathology
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology
  • omega-N-Methylarginine

Substances

  • Enzyme Inhibitors
  • Isoantigens
  • Mitogens
  • Concanavalin A
  • Interleukin-4
  • omega-N-Methylarginine
  • Nitric Oxide
  • Interferon-gamma
  • Arginine
  • Nitric Oxide Synthase